產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C15orf52抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C15orf52抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C15orf52
Cat. Number:
Anti-C15orf52抗體KL-9620R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Encoding more than 700 genes, chromosome 15 is made up of approximately 106 million base pairs and is about 3% of the human genome. Angelman and Prader-Willi syndromes are associated with loss of function or deletion of genes in the 15q11-q13 region. In the case of Angelman syndrome, this loss is due to inactivityAnti-C15orf52抗體 of the maternal 15q11-q13 encoded UBE3A gene in the brain by either chromosomal deletion or mutation. In cases of Prader-Willi syndrome, there is a partial or complete deletion of this region from the paternal copy of chromosome 15. Tay-Sachs disease is a lethal disorder associated with mutations of the HEXA gene, which is encoded by chromosome 15. Marfan syndrome is associated with chromosome 15 through the FBN1 gene. The C15orf52 gene product has been provisionally designated C15orf52 pending further characterization.
Also known as:
chromosome 15 openAnti-C15orf52抗體 reading frame 52; DKFZp686N1468; FLJ43339; hypothetical protein LOC388115; CO052_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C15orf52.
●
Predicted Molecular Weight: 57kDa.
Storage:
Shipped at 4℃, StoreAnti-C15orf52抗體 at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal workingAnti-C15orf52抗體 dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal workingAnti-C15orf52抗體 dilutions must be determined by the end user.
kl776Mu02 丙酮酸脫氫酶α(PDHα)多克隆抗體 Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl778Bo01 B-細(xì)胞**瘤因子2(Bcl2)多克隆抗體 Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Mu02 B-細(xì)胞**瘤因子2(Bcl2)多克隆抗體 Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl785Mu02 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl786Mu02 纖維膠凝蛋白1(FCN1)多克隆抗體 Polyclonal Antibody to Ficolin 1 (FCN1)
kl786Ra01 纖維膠凝蛋白1(FCN1)多克隆抗體 Polyclonal Antibody to Ficolin 1 (FCN1)
kl788Mu02 細(xì)胞程序性死亡蛋白1配體1(PDCD1LG1)多克隆抗體 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl789Hu01 細(xì)胞程序性死亡蛋白1配體2(PDCD1LG2)多克隆抗體 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 2 (PDCD1LG2)
kl790Mu02 腫瘤壞死因子受體超家族成員17(TNFRSF17)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17)
kl791Mu02 骨粘連蛋白(ON)多克隆抗體 Polyclonal Antibody to Osteonectin (ON)
kl792Mu02 拓?fù)洚悩?gòu)酶Ⅱ(TOP2)多克隆抗體 Polyclonal Antibody to Topoisomerase II (TOP2)
kl792Ra01 拓?fù)洚悩?gòu)酶Ⅱ(TOP2)多克隆抗體 Polyclonal Antibody to Topoisomerase II (TOP2)
kl794Mu02 周期素依賴性激酶抑制因子2A(CDKN2A)多克隆抗體 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl797Mu02 血管緊張素原(AGT)多克隆抗體 Polyclonal Antibody to Angiotensinogen (AGT)
kl798Mu02 低氧誘導(dǎo)因子1α(HIF1α)多克隆抗體 Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
